The store will not work correctly when cookies are disabled.
N-(2-amino-4-fluoro-phenyl)-3-(1-cinnamylpyrazol-4-yl)prop-2-enamide
ID: ALA5195471
PubChem CID: 68294530
Max Phase: Preclinical
Molecular Formula: C21H19FN4O
Molecular Weight: 362.41
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1cc(F)ccc1NC(=O)C=Cc1cnn(CC=Cc2ccccc2)c1
Standard InChI: InChI=1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11,13-15H,12,23H2,(H,25,27)
Standard InChI Key: BLVQHYHDYFTPDV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-5.6804 0.0426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9659 0.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2540 0.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2540 -0.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9641 -1.1939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6804 -0.7858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5393 0.4556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8247 0.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1101 0.4556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3954 0.0430 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6420 0.3784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0900 -0.2344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5025 -0.9487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3092 -0.7772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7345 -0.2344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1468 0.4797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9716 0.4797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3839 1.1939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3839 -0.2344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2085 -0.2344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6211 0.4796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4433 0.4789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8558 -0.2355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4469 -0.9469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6227 -0.9517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2088 1.1938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6804 -0.2355 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
7 8 2 3
8 9 1 0
9 10 1 0
11 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
12 15 1 0
15 16 2 3
16 17 1 0
17 18 2 0
17 19 1 0
19 20 1 0
21 20 2 0
22 21 1 0
23 22 2 0
24 23 1 0
25 24 2 0
20 25 1 0
21 26 1 0
23 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 362.41 | Molecular Weight (Monoisotopic): 362.1543 | AlogP: 3.97 | #Rotatable Bonds: 6 |
Polar Surface Area: 72.94 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.46 | CX LogP: 3.65 | CX LogD: 3.65 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.51 | Np Likeness Score: -1.36 |